Martin Simonetti

Martin Simonetti

Chief Executive Officer at
PBS Biotech, Inc.
68 year
Health Technology
Consumer Services
Commercial Services

Profile

Martin A. Simonetti is Chief Executive Officer at PBS Biotech, Inc. since 2025.
Mr. Simonetti is Director at Curtana Pharmaceuticals, Inc. since 2015.
Mr. Simonetti is Director at LoveMyDelta, Inc. Mr. Simonetti is Director at Eisana Corp.
Formerly, Mr. Simonetti was President & Chief Executive Officer at Viral Logic Systems Technology Corp.
from 2005 to 2011.
Mr. Simonetti was Chairman at Nexgenia, Inc. Mr. Simonetti was Independent Director at Alexandria Real Estate Equities, Inc. from 2011 to 2013.
Mr. Simonetti was Independent Director at Neusentis, Inc. in 2011.
Mr. Simonetti was Director at Prismic Pharmaceuticals, Inc. Mr. Simonetti was Director at EpiThany, Inc. Mr. Simonetti was Vice President-Operations & Finance at Amgen, Inc. in 1998.
Mr. Simonetti was Group Controller at Genentech, Inc. in 1991.
Mr. Simonetti was Chief Financial Officer, Treasurer & SVP-Finance at Dendreon Corp.
from 1999 to 2005.
Education includes an MBA from Santa Clara University and graduate studies at the University of California, Davis.

Martin Simonetti active positions

CompaniesPositionStart
Director/Board Member 2015-07-31
Director/Board Member -
Chief Executive Officer 2025-10-26
Director/Board Member -

Former positions of Martin Simonetti

CompaniesPositionEnd
ALEXANDRIA REAL ESTATE EQUITIES, INC. Director/Board Member 2013-05-19
Director/Board Member 2011-10-26
DENDREON CORPORATION Director of Finance/CFO 2005-06-09
AMGEN INC. Director of Finance/CFO 1997-12-31
Comptroller/Controller/Auditor 1990-12-31
See the detail of Martin Simonetti's experience

Training of Martin Simonetti

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Technology Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Martin Simonetti